Can aripiprazole (Abilify) cause seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Abilify Cause Seizures?

Yes, aripiprazole (Abilify) can cause seizures, though the risk is low at 0.1% in clinical trials, and it should be used cautiously in patients with a history of seizures or conditions that lower the seizure threshold. 1

Seizure Risk Profile

The FDA label explicitly warns that seizures/convulsions occurred in 0.1% (3/2,467) of adult patients and 0.1% (1/732) of pediatric patients (6-18 years) treated with oral aripiprazole in short-term, placebo-controlled trials 1. Importantly, these trials excluded patients with a known history of seizures, meaning the actual risk in real-world populations may differ.

Clinical Context and Risk Stratification

Use aripiprazole cautiously in patients with:

  • History of seizures
  • Conditions that lower seizure threshold (head trauma, metabolic disorders, alcohol withdrawal)
  • Age ≥65 years (conditions lowering seizure threshold are more prevalent) 1

Comparative Risk Among Antipsychotics

Recent large-scale pharmacovigilance data demonstrates that aripiprazole carries a moderate seizure signal compared to other atypical antipsychotics. At the High-Level Group Term level, aripiprazole showed a reporting odds ratio (ROR) of 2.05, which is lower than ziprasidone (3.21), quetiapine (2.62), clozapine (2.58), and olanzapine (2.53) 2. This positions aripiprazole in the middle range of seizure risk among second-generation antipsychotics.

A 2015 UK study found that in patients with affective disorders, aripiprazole (grouped with amisulpride, risperidone, and sulpiride) was not associated with increased seizure risk compared to non-use of antipsychotics 3. However, in patients with dementia, this same drug class also showed no significant association (adjusted OR 0.92,95% CI 0.48-1.75) 3.

Pediatric data from Korea (2021) revealed that aripiprazole was independently associated with greater seizure risk in children and adolescents with psychiatric disorders, with risk increasing further when multiple antipsychotics were used concurrently 4.

Case Reports and Mechanistic Considerations

While rare, case reports document aripiprazole-induced seizures in both adults 5 and children 6. One notable pediatric case involved a 3-year-old who experienced prolonged lethargy, dystonia, and two witnessed seizures after ingesting 30 mg of aripiprazole 6.

The mechanism may relate to aripiprazole's receptor profile. Recent analysis suggests an inverse correlation between the 5-HT1A/D2 receptor affinity ratio and seizure risk (rs = -0.79, p = 0.036), indicating that drugs with lower 5-HT1A relative to D2 activity may carry higher seizure liability 2.

Clinical Recommendations

When prescribing aripiprazole:

  1. Screen for seizure risk factors before initiation:

    • Personal or family history of seizures
    • Structural brain lesions (tumors, stroke, trauma)
    • Metabolic abnormalities
    • Concurrent medications that lower seizure threshold
    • Alcohol or substance use disorders
  2. In high-risk patients, consider alternative antipsychotics with lower seizure liability (risperidone, paliperidone, lurasidone) 2, 3

  3. Monitor closely during:

    • Treatment initiation
    • Dose escalation
    • Addition of other medications that may interact
  4. Educate patients about seizure warning signs and when to seek immediate care

Special Populations

Brain tumor patients: Aripiprazole is associated with lower seizure risk compared to clozapine and low-potency first-generation antipsychotics in this uniquely vulnerable population with already compromised seizure thresholds 7.

Pediatric patients: Exercise heightened vigilance, as pediatric populations may be more susceptible to antipsychotic-related seizures, particularly when using multiple agents 4, 6.

Common Pitfalls to Avoid

  • Do not assume zero risk simply because aripiprazole is a "third-generation" antipsychotic—seizures can occur
  • Do not overlook polypharmacy effects—concurrent use of multiple antipsychotics or medications that lower seizure threshold amplifies risk 4
  • Do not dismiss atypical presentations—seizures may present with altered mental status, dystonia, or prolonged lethargy rather than classic convulsions 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.